Yes, within the boundary of what your approved indication and claims allow, which shapes the keyword strategy from the start rather than being a constraint applied afterward.
The keywords available for a prescription drug are bounded by your approved indication, not by search volume. A term with high volume that implies an unapproved use is simply not usable, regardless of its ranking potential, so the research has to start from the regulatory boundary rather than a keyword tool.
HCP-facing content about mechanism and clinical evidence, corporate and unbranded disease-awareness content, and technical SEO fixing structural issues that block indexation entirely all remain fully available. See pharmaceutical SEO for how the strategy is built around your approved claims from the outset.
The technical fundamentals — site structure, indexability, multilingual targeting — are identical to any other SEO work and are frequently where the largest, fastest gains actually are, unconstrained by the claims boundary.
Often, yes, provided the content stays unbranded and non-promotional rather than steering toward a specific product, since condition-level searches are generally treated as informational rather than advertising. See disease awareness website for how that unbranded content is typically structured to rank without crossing into promotional territory.
Yes, though results depend heavily on how tightly regulated the specific therapeutic area is and how much unbranded, non-promotional content your medical review process allows you to publish. See does SEO work for pharma for the fuller answer on timelines and what typically drives results.
Your regulatory and medical function defines the approved claims and the boundary between informational and promotional content, and the SEO strategy is built around what they confirm rather than the other way round. This sequencing matters, since content built ahead of approval is often reworked or scrapped later.
No, paid search is typically more restricted, since platforms like Google require pharmaceutical advertiser certification before serving most prescription drug ads, while organic ranking for unbranded, non-promotional content faces no such platform-level gate. The two channels are worth planning separately rather than assuming one approval covers both.
Tell us your approved indication and we will tell you what SEO opportunity actually exists inside it.